# Delivery Order #15B40827F00000033

McKesson Delivery Order for Controlled Pharmaceuticals under VA Prime Vendor Contract

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $80.73
**Ceiling:** $80.73

**Awarded:** November 01, 2026
**Period of Performance:** Nov 01, 2026 - Nov 30, 2026

**Identifier:** 15B40827F00000033
**NAICS:** 325412

This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) known as the Pharmaceutical Prime Vendor Contract (PPV), managed by the Department of Veterans Affairs (VA). The recipient, McKesson Corporation, is a leading pharmaceutical distribution company tasked with supplying a broad range of pharmaceutical products to the VA. This specific delivery order pertains to controlled pharmaceuticals, emphasizing McKesson's role in securely managing sensitive medication supplies to meet stringent VA requirements. The contract's significance lies in supporting the VA's mission to ensure veterans have reliable and timely access to essential medications, thereby enhancing healthcare outcomes for the veteran population. The scope of work includes the distribution and controlled delivery of pharmaceutical products within a specified one-month period, fitting within the larger multi-year, substantial-value prime vendor program. The delivery order was awarded competitively under the broader PPV contract vehicle, which was originally awarded through open competition without set-aside restrictions. The period of performance for this delivery order is a short-term interval in November 2026, aligning with the ongoing support framework established by the parent PPV IDV that McKesson holds since 2020. This award underlines McKesson's continuing role in maintaining an efficient pharmaceutical supply chain for the VA healthcare system.

### Description

MCKESSON CONTROLLED PHARMACEUTICALS FY27 NOVEMBER 2026 IAW T&C: 36W79720D0001

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B40827F00000033_1540_36W79720D0001_3600)
